Medivalent

ocrelizumab

WHO ATC code: L04AA36
Also known as: ocrelizumab acetate · ocrelizumab besylate · ocrelizumab calcium · ocrelizumab citrate · ocrelizumab dihydrochloride · ocrelizumab fumarate

Available in 6 countries

United Kingdom5
- Ocrevus 920mg/23ml solution for injection vialsOTC
- Ocrelizumab 300mg/10ml solution for infusion vialsOTC
- Ocrelizumab 920mg/23ml solution for injection vialsOTC
See all ocrelizumab in United Kingdom →
Switzerland2
- Ocrevus
- Ocrevus subkutan 920 mg/23 ml
See all ocrelizumab in Switzerland →
France2
- OCREVUS 920 mg, solution injectable
- OCREVUS 300 mg, solution à diluer pour perfusion
See all ocrelizumab in France →
Canada1
- OCREVUS
See all ocrelizumab in Canada →
Spain1
- OCREVUS 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
See all ocrelizumab in Spain →
Netherlands1
- Ocrevus 920 mg oplossing voor injectie
See all ocrelizumab in Netherlands →